NEW YORK — Patients need to be motivated before beginning therapy for geographic atrophy, according to a speaker at OSN New York Retina.
Christina Y. Weng, MD, MBA, FASRS, said clinical factors, like risk for fast progression, are an important part of her decision making process when considering medical therapy for patients with GA. However, there is another important factor that might not immediately come to mind for clinicians.
“It's not on a lot of our lists when we're considering treatment, but it really is probably one of the most important factors that I think about, which is patient